Radio and PodcastRadio and PodcastLive Radio & Podcasts
161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal artwork
Science & Medicine

161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal

New FDA Approvals

Jul 23, 201809:24Science & Medicine

161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal - New FDA Approvals

Related Episodes

Continue listening to more episodes from New FDA Approvals.